BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23237038)

  • 1. Vitiligo road map.
    Lee BW; Schwartz RA; Hercogová J; Valle Y; Lotti TM
    Dermatol Ther; 2012; 25 Suppl 1():S44-56. PubMed ID: 23237038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatments of vitiligo: what's new at the horizon.
    Lotti TM; Hercogová J; Schwartz RA; Tsampau D; Korobko I; Pietrzak A; Mitrevska NT; Valle Y; Buggiani G
    Dermatol Ther; 2012; 25 Suppl 1():S32-40. PubMed ID: 23237036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo: an update on current pharmacotherapy and future directions.
    Colucci R; Lotti T; Moretti S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitiligo nonsurgical treatment: a review of latest treatment researches.
    Zhang Y; Mooneyan-Ramchurn JS; Zuo N; Feng Y; Xiao S
    Dermatol Ther; 2014; 27(5):298-303. PubMed ID: 25041437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo.
    Yu HS; Wu CS; Yu CL; Kao YH; Chiou MH
    J Invest Dermatol; 2003 Jan; 120(1):56-64. PubMed ID: 12535198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of vitiligo patients with surgical interventions.
    Shokeen D
    Cutis; 2016 May; 97(5):E27-9. PubMed ID: 27274556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review.
    Ju HJ; Bae JM
    Dermatology; 2024; 240(3):474-486. PubMed ID: 38417409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of current clinical studies of vitiligo treatments.
    Korobko IV
    Dermatol Ther; 2012; 25 Suppl 1():S17-27. PubMed ID: 23237034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo: to treat or not to treat.
    Lim HW; Hexsel CL
    Arch Dermatol; 2007 May; 143(5):643-6. PubMed ID: 17515516
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitiligo: An Update on Pathophysiology and Treatment Options.
    Speeckaert R; van Geel N
    Am J Clin Dermatol; 2017 Dec; 18(6):733-744. PubMed ID: 28577207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitiligo. Pathogenesis and treatment.
    Njoo MD; Westerhof W
    Am J Clin Dermatol; 2001; 2(3):167-81. PubMed ID: 11705094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversial issues in vitiligo patients: a review of old and recent treatments.
    Lotti T; Gianfaldoni S; Valle Y; Rovesti M; Feliciano C; Satolli F
    Dermatol Ther; 2019 Jan; 32(1):e12745. PubMed ID: 30221810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.